• Activity Title

    Start Activity

    Effects of Thyroid Dysfunction on Women’s Health

     

  • Description

    The following learning activity will focus on women experiencing thyroid dysfunction (known and unknown) and outline manifestations, complaints, and symptoms seen in this population. Guideline-based thyroid testing will be reviewed and then followed with patient case studies to review materials. The activity offers in-depth clinical examples and highlights the implications of thyroid testing and diagnosis.

  • Target Audience

    This activity is intended for clinical and scientific laboratory professionals, physician - scientists who have an interest in thyroid disease.

  • Learning Objectives

    After completing the activity, the participant should be better able to:

    • Define common signs & symptoms for women who have thyroid dysfunction.
    • Understand women’s health impacts due to thyroid dysfunction.
    • Outline thyroid testing guidelines for clinicians based on main complications observed in women with thyroid dysfunction.
    • Recognize the symptoms, how to diagnosis, and how to test for thyroid dysfunction by using patient case studies.

    Instruction Level: Intermediate

  • Speaker

    Shannon K. Idzik, DNP
    Professor, Organizational Systems and Adult Health
    Associate Dean for the DNP Program
    University of Maryland School of Nursing
    Baltimore, Maryland

    Mark A. Lupo, MD
    Medical Director, Thyroid and Endocrine Center of Florida
    Assistant Clinical Professor of Medicine
    Florida State University, College of Medicine
    Sarasota, Florida

  • Duration

    1.0 hour

  • Release and Expiration Dates

    Release Date: August 15, 2025
    Expiration Date: August 15, 2027

  • Disclosures

    The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.

    Shannon K. Idzik, DNP
    -Nothing to disclose

    Mark A. Lupo, MD
    -Consulting Fee: Eisai, Interpace Diagnostics, Quidel-Ortho, Horizon/Amgen, Viridian, Immunovant, Abbvie
    -Contracted Research: Roche, Quidel-Ortho, Takeda
    -Speakers Bureau: Elsai, Interpace Diagnostics, Abbvie, Quidel-Ortho

  • P.A.C.E.® Accreditation

    QuidelOrtho is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

  • Start Activity

  • Policy on Privacy and Confidentiality

    QuidelOrtho Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. QuidelOrtho Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

    QuidelOrtho Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.

  • Medium Used

    This program has been made available online.
    “EGFR FISH in Lung Cancer Therapy Selection”

  • Commercial Support Statement

    This activity is provided by the QuidelOrtho Corporation.

  • System Requirements

    To view this educational activity, you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases, we recommend the use of computers.

  • Copyright

    Copyright © QuidelOrtho Corporation.

  • Web interface provided by Dane Garvin Ltd.

     

Contact Us